SCHEMBL1690675

SCHEMBL1690675

COc1ccc(CN(c2ncccn2)S(=O)(=O)c2cc(Cl)c(Oc3ccc(-c4ccc(C(F)(F)F)cc4)cc3-c3ccnc(N4CCN(C(=O)OC(C)(C)C)CC4)c3)cc2F)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 8/20 0.38
ITGB2 P05107 2/20 0.36
ICAM1 P05362 2/20 0.36
ITGAL P20701 2/20 0.36
PGK1 P00558 1/20 0.36
GALR2 O43603 1/20 0.36
GALR1 P47211 1/20 0.36
RET P07949 1/20 0.35
MAPK10 P53779 2/20 0.35
SUV39H2 Q9H5I1 2/20 0.34
CYP2C9 P11712 2/20 0.34
SCN5A Q14524 1/20 0.34
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN8A Q9UQD0 1/20 0.34
TP53 P04637 1/20 0.34
MDM2 Q00987 1/20 0.34
WNT3A P56704 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1690648 0.94 SCN9A (0.39) SCN9AITGB2ICAM1ITGALMAPK10
SCHEMBL1690629 0.92 SCN9A (0.35) SCN9AITGB2ICAM1ITGALPGK1
SCHEMBL10185797 0.91 SCN9A (0.42) SCN9ACYP2C9SCN5ASCN1ASCN2A
SCHEMBL322805 0.85 SCN9A (0.43) SCN9ACYP2C9SCN5ASCN1ASCN2A
SCHEMBL1690602 0.83 SCN9A (0.52) SCN9ACYP2C9SCN5ASCN1ASCN2A
SCHEMBL17293706 0.80 SCN9A (0.41) SCN9ARETCYP2C9SCN5ASCN1A
SCHEMBL10147882 0.77 SCN9A (0.53) SCN9ACYP2C9SCN5ASCN1ASCN2A
SCHEMBL1690594 0.76 SCN9A (0.50) SCN9ACYP2C9SCN1ASCN2ASCN8A
SCHEMBL10185423 0.74 SCN9A (0.51) SCN9ACYP2C9SCN5ASCN1ASCN2A
SCHEMBL1690576 0.74 SCN9A (0.56) SCN9ACYP2C9SCN5ASCN1ASCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590951-B1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS PFIZER LTD (GB) 2015-01-07 EP disclosed
EP-2590951-B1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS PFIZER LTD (GB) 2015-01-07 EP disclosed
US-8772293-B2 Chemical compounds PFIZER LIMITED (GB) 2014-07-08 US disclosed
US-8772293-B2 Chemical compounds PFIZER LIMITED (GB) 2014-07-08 US disclosed
US-8772293-B2 Chemical compounds PFIZER LIMITED (GB) 2014-07-08 US disclosed
WO-2012004743-A1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS PFIZER LIMITED (GB) 2012-01-12 WO disclosed
US-20120010182-A1 Chemical Compounds ICAGEN INC. (US) 2012-01-12 US disclosed
US-20120010182-A1 Chemical Compounds ICAGEN INC. (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010182-A1 Chemical Compounds SCN1A, SCN1B, CACNA1E SCN9A 12/4885ITGB2 3340/4885ICAM1 828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.